Structure based design of a series of potent and selective non peptidic PTP-1B inhibitors

被引：77

作者：

Lau, CK

Bayly, CI

Gauthier, JY

Li, CS

Therien, M

Asante-Appiah, E

Cromlish, W

Boie, Y

Forghani, F

Desmarais, S

Wang, QP

Skorey, K

Waddleton, D

Payette, P

Ramachandran, C

Kennedy, BP

Scapin, G

机构：

[1] Merck Frosst Ctr Therapeut Res, Dept Med Chem, Pointe Claire, PQ H9R 4P8, Canada

[2] Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, Pointe Claire, PQ H9R 4P8, Canada

[3] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 04期

关键词：

D O I：

10.1016/j.bmcl.2003.11.076

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of benzotriazole phenyldifluoromethylphosphonic acids were found to be potent PTP-1B inhibitors. Molecular modeling on the X-ray crystal structure of the lead structure led to the design of potent PTP-1B inhibitors that show moderate selectivity against TC-PTP, a very closely related protein tyrosine phosphatase. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：1043 / 1048

页数：6

共 14 条

[1] Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes
Ahmad, F
Azevedo, JL
Cortright, R
Dohm, GL
Goldstein, BJ
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (02) : 449 - 458
[2] INCREASED ABUNDANCE OF THE RECEPTOR-TYPE PROTEIN-TYROSINE-PHOSPHATASE LAR ACCOUNTS FOR THE ELEVATED INSULIN-RECEPTOR DEPHOSPHORYLATING ACTIVITY IN ADIPOSE-TISSUE OF OBESE HUMAN-SUBJECTS
AHMAD, F
CONSIDINE, RV
GOLDSTEIN, BJ
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) : 2806 - 2812
[3] OSMOTIC LOADING OF NEUTRALIZING ANTIBODIES DEMONSTRATES A ROLE FOR PROTEIN-TYROSINE-PHOSPHATASE 1B IN NEGATIVE REGULATION OF THE INSULIN ACTION PATHWAY
AHMAD, F
LI, PM
MEYEROVITCH, J
GOLDSTEIN, BJ
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (35) : 20503 - 20508
[4] Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin
Bandyopadhyay, D
Kusari, A
Kenner, KA
Liu, F
Chernoff, J
Gustafson, TA
Kusari, J
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) : 1639 - 1645
[5] Development and validation of an intact cell assay for protein tyrosine phosphatases using recombinant baculoviruses
Cromlish, WA
Payette, P
Kennedy, BP
[J]. BIOCHEMICAL PHARMACOLOGY, 1999, 58 (10) : 1539 - 1546
[6] Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
Elchebly, M
Payette, P
Michaliszyn, E
Cromlish, W
Collins, S
Loy, AL
Normandin, D
Cheng, A
Himms-Hagen, J
Chan, CC
Ramachandran, C
Gresser, MJ
Tremblay, ML
Kennedy, BP
[J]. SCIENCE, 1999, 283 (5407) : 1544 - 1548
[7] 3,4-fluorescein diphosphate: A sensitive fluorogenic and chromogenic substrate for protein tyrosine phosphatases
Huang, Z
Wang, QP
Ly, HD
Gorvindarajan, A
Scheigetz, J
Zamboni, R
Desmarais, S
Ramachandran, C
[J]. JOURNAL OF BIOMOLECULAR SCREENING, 1999, 4 (06) : 327 - 334
[8] Protein tyrosine phosphatase 1B inhibitors for diabetes
Johnson, TO
Ermolieff, J
Jirousek, MR
[J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (09) : 696 - 709
[9] Protein tyrosine phosphatase-1B in diabetes
Kennedy, BP
Ramachandran, C
[J]. BIOCHEMICAL PHARMACOLOGY, 2000, 60 (07) : 877 - 883
[10] Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling
Kenner, KA
Anyanwu, E
Olefsky, JM
Kusari, J
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (33) : 19810 - 19816

← 1 2 →